浏览全部资源
扫码关注微信
1.新疆医科大学药学院,乌鲁木齐 830011
2.新疆医科大学第一附属医院药学部,乌鲁木齐 830011
硕士。研究方向:中药复方肝保护作用及机制。E-mail:1595527349@qq.com
教授,博士生导师,博士。研究方向:新疆特色药用植物资源开发利用。E-mail:hjp-yft@163.com
纸质出版日期:2023-08-30,
收稿日期:2023-03-24,
修回日期:2023-07-19,
扫 描 看 全 文
阿依孜巴·图尔洪 ,杨建华,王晓梅等.护肝布祖热方对大鼠肝内胆汁淤积性肝损伤的影响及机制 Δ[J].中国药房,2023,34(16):1943-1948.
Ayiziba·Tuerhong ,YANG Jianhua,WANG Xiaomei,et al.Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats[J].ZHONGGUO YAOFANG,2023,34(16):1943-1948.
阿依孜巴·图尔洪 ,杨建华,王晓梅等.护肝布祖热方对大鼠肝内胆汁淤积性肝损伤的影响及机制 Δ[J].中国药房,2023,34(16):1943-1948. DOI: 10.6039/j.issn.1001-0408.2023.16.05.
Ayiziba·Tuerhong ,YANG Jianhua,WANG Xiaomei,et al.Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats[J].ZHONGGUO YAOFANG,2023,34(16):1943-1948. DOI: 10.6039/j.issn.1001-0408.2023.16.05.
目的
2
研究护肝布祖热方(HBF)对大鼠肝内胆汁淤积性肝损伤的影响及潜在机制。
方法
2
将大鼠随机分为对照组(control组)、模型组(model组)、熊去氧胆酸(UDCA)组(阳性对照,60 mg/kg)和HBF低、中、高剂量组(HBF-L、HBF-M、HBF-H组,0.4、0.8、1.6 g/kg),每组6只。各药物组大鼠每天灌胃相应药液1次,连续7 d;control组和model组大鼠灌胃等体积水。实验第5天,除control组外,其余各组大鼠均单次灌胃
α
-异硫氰酸萘酯橄榄油溶液(100 mg/kg)建模。造模48 h后,检测大鼠血清中肝功能指标(天冬氨酸转氨酶、丙氨酸转氨酶、碱性磷酸酶、总胆汁酸、总胆红素、直接胆红素)含量和氧化应激指标[丙二醛(MDA)、谷胱甘肽(GSH)、超氧化物歧化酶]水平,观察肝组织病理形态变化,检测肝组织中炎症相关因子[肿瘤坏死因子α(TNF-α)和白细胞介素1β(IL-1β)]
和法尼酯X受体(FXR)信号通路相关因子[FXR、小异源二聚体伴侣受体(SHP)、多药耐药蛋白2(MRP2)、胆盐输出泵转运蛋白(BSEP)、钠离子依赖性牛磺胆酸共转运蛋白(NTCP)、有机阴离子转运多肽2(OATP2)和胆固醇7α羟化酶(CYP7A1)]mRNA,以及FXR信号通路相关蛋白(FXR、MRP2、BSEP、NTCP)和核因子κB p65(NF-κB p65)蛋白的表达情况。
结果
2
与model组比较,HBF-H组大鼠血清中上述肝功能指标含量和MDA水平,肝组织中上述炎症相关因子mRNA、CYP7A1 mRNA的表达水平以及NF-κB p65蛋白的相对表达量均显著降低,血清中GSH水平和肝组织中FXR、SHP、MRP2、BSEP、NTCP、OATP2 mRNA的表达水平以及FXR、MRP2、BSEP、NTCP蛋白的相对表达量均显著升高(
P
<0.05或
P
<0.01),肝组织病理改变明显好转;HBF-L组、HBF-M组、UDCA组大鼠均只有部分指标显著逆转(
P
<0.05或
P
<0.01)。
结论
2
HBF可预防大鼠肝内胆汁淤积性肝损伤,此作用可能与激活FXR信号通路、减轻炎症和氧化应激有关。
OBJECTIVE
2
To study the effects of Hugan buzure formula (HBF) on intrahepatic cholestatic liver injury in rats and its potential mechanism.
METHODS
2
Rats were randomly divided into control group, model group, ursodeoxycholic acid (UDCA) group (positive control, 60 mg/kg ) and HBF low-dose, middle-dose and high-dose groups (HBF-L, HBF-M, HBF-H groups, 0.4, 0.8, 1.6 g/kg ), with 6 rats in each group. The rats in each drug group were given the corresponding drug solution intragastrically, once a day, for 7 consecutive days. The rats in the control group and the model group were given equal volumes of water intragastrically. On the 5th day, except for the control group, the rats in other groups were single intragastrically administered with alpha-naphthyl isothiocyanate olive oil solution (100 mg/kg) to establish the model. After 48 h of modeling, the contents of liver function indexes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total bile acid, total bilirubin, direct bilirubin) and oxidative stress indexes [malondialdehyde (MDA), glutathione (GSH), superoxide dismutase] in serum of rats were detected; the pathological changes of liver tissue were observed. The mRNA expressions of inflammation-related factors [tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β)]
and farnesoid X receptor (FXR) signaling pathway-related factors [FXR, small heterodimer partner (SHP), multidrug resistance protein 2 (MRP2), bile salt export pump (BSEP), Na
+
-taurocholate cotransporting polypeptide (NTCP), organic anion-transporting polypeptide 2 (OATP2) and cholesterol 7α-hydroxylase (CYP7A1)], the expressions of FXR signaling pathway-related proteins (FXR, MRP2, BSEP, NTCP) and nuclear factor-κB p65 (NF-κB p65) in liver tissue were detected.
RESULTS
2
Compared with the model group, the contents of liver function indexes and the level of MDA in serum, the mRNA expressions of the above inflammation-related factors and CYP7A1, and the relative expression of NF-κB p65 in liver tissue were significantly decreased; the levels of GSH in serum, the mRNA expressions of FXR, SHP, MRP2, BSEP, NTCP and OATP2, and the relative expressions of FXR, MRP2, BSEP and NTCP in liver tissue were significantly increased (
P
<0.05 or
P
<0.01); the pathological changes of liver tissue were significantly improved. Only some indexes in HBF-L group, HBF-M group and UDCA group were significantly reversed (
P
<0.05 or
P
<0.01).
CONCLUSIONS
2
HBF can prevent intrahepatic cholestatic liver injury in rats, and the effects may be related to the activation of FXR signaling pathway and the reduction of inflammation and oxidative stress.
护肝布祖热方肝内胆汁淤积性肝损伤法尼酯X受体信号通路炎症反应氧化应激
intrahepatic cholestatic liver injuryfarnesoid X receptor signaling pathwayinflammatory reactionoxidative stress
ZOU M Z,WANG A Z,WEI J J,et al. An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis[J]. Int Immunopharmacol,2021,92:107328.
ZHANG R J,HUANG T,ZHANG Q Y,et al. Xiaoyan Lidan formula ameliorates α-naphthylisothiocyanate-in-duced intrahepatic cholestatic liver injury in rats as revealed by non-targeted and targeted metabolomics[J]. J Pharm Biomed Anal,2020,179:112966.
NIETSCHE T R,DOTTA G,BARCAUI C B,et al. Cholestatic pruritus:a knowledge update[J]. An Bras Dermatol,2022,97(3):332-337.
杨建华,杨秀娟,赵耀,等. 护肝布祖热对CCl4诱导人肝星状细胞LX-2活化的作用及机制研究[J]. 中药新药与临床药理,2022,33(10):1315-1321.
杨秀娟,杨建华,何红艳,等. 维吾尔药方护肝布祖热抗大鼠急性肝损伤作用的研究[J]. 新疆医科大学学报,2017,40(11):1479-1483,1491.
何红艳,杨建华,杨秀娟,等. 维药护肝布祖热对四氯化碳诱导肝纤维化大鼠的保护作用[J]. 中药药理与临床,2018,34(6):19-22.
郑士宏. 芹菜素对DDC诱导的胆汁淤积性肝病的保护作用[D]. 合肥:合肥工业大学,2021.
李国栋,杨金玉,马小华,等. 清热卡森颗粒对肝内胆汁淤积大鼠模型的治疗作用及机制研究[J]. 世界科学技术-中医药现代化,2022,24(10):4038-4046.
MENG F C,ZONG W,WEI X D,et al. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid X receptor-mediated bile acid metabolism[J]. Phytomedicine,2021,87:153588.
WANG C,PENG F,ZHONG B H,et al. Metabolomic analysis reveals the therapeutic effects of MBT1805,a novel pan-peroxisome proliferator-activated receptor agonist,on α-naphthylisothiocyanate-induced cholestasis in mice[J]. Front Pharmacol,2021,12:732478.
TELBISZ Á,HOMOLYA L. Recent advances in the exploration of the bile salt export pump(BSEP/ABCB11)function[J]. Expert Opin Ther Targets,2016,20(4):501-514.
YAO H,XU Y W,YIN L H,et al. Dioscin protects ANIT-induced intrahepatic cholestasis through regulating tran-sporters,apoptosis and oxidative stress[J]. Front Pharmacol,2017,8:116.
LI X,LIU R P,YU L X,et al. Alpha-naphthyliso-thiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes[J]. Toxicology,2016,370:106-115.
XU L L,SHENG T T,LIU X L,et al. Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes[J]. J Ethnopharmacol,2017,209:91-99.
WEI X D,MA Y X,DONG Z Y,et al. Dehydrodiconiferyl alcohol,a lignan from Herpetospermum pedunculosum,alleviates cholestasis by activating pathways associa-ted with the farnesoid X receptor[J]. Phytomedicine,2021,80:153378.
PANZITT K,ZOLLNER G,MARSCHALL H U,et al. Recent advances on FXR-targeting therapeutics[J]. Mol Cell Endocrinol,2022,552:111678.
连雅君. 清开灵对胆汁淤积性肝炎大鼠证候干预及肝损伤机制的研究[D]. 北京:北京中医药大学,2018.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构